NASDAQ:CTKB | Free Cash Flow | Cytek Biosciences, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2020-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$2.74M$2.17M-$4.9M
2025-12-31-$771,000.00$1M-$1.77M
2025-03-31-$125,000.00$849,000.00-$974,000.00
2024-12-31$2M$894,000.00$1.1M11.44%
2024-03-31$3.96M$567,000.00$3.39M
2023-12-31$9.51M$1.5M$8.01M145.59%
2023-03-31$2.86M$505,000.00$2.35M
2022-12-31$6.19M$6.53M-$337,000.00-9.06%
2022-03-31-$1.48M$780,000.00-$2.26M
2021-12-31$5.45M$1.3M$4.15M
2021-03-31$1.94M$509,000.00$1.43M1398.04%
2020-12-31$11.64M$203,000.00$11.44M204.29%

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$4.69M$4.08M-$8.77M
2024-12-31$25.38M$3.53M$21.85M
2023-12-31$5.28M$4.65M$633,000.00
2022-12-31-$12.23M$9.75M-$21.98M-884.82%
2021-12-31$4.63M$4.36M$266,000.008.79%
2020-12-31$15.16M$1.55M$13.61M70.11%